We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Sperm Analyzer Offers Enhanced Performance, Flexibility, and Standardization

By LabMedica International staff writers
Posted on 10 Aug 2015
A new automated sperm-quality analyzer includes enhancement features such as a high-definition touch-screen interface, expanded testing options, and state-of-the-art digital magnification with “click-to-mark” interface. More...
The analyzer will be exhibited by Medical Electronic Systems (MES; Los Angeles, CA, USA) at the Clinical Lab Expo of AACC 2015 (July 26-30; Atlanta, GA, USA).

The “SQA-Vision” analyzer was developed based on 10 years of market feedback and is positioned to augment MES’s line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

“MES has placed greater than 3,750 semen analyzers globally in over 45 countries. This market penetration provided us with the unique opportunity to develop the SQA-Vision based on a wealth of customer feedback. The SQA-Vision will profoundly impact the way semen analysis is conducted in laboratories worldwide with rapid, standardized and accurate test results, customized reporting and greatly expanded testing options which strictly adhere to WHO guidelines,” said Eric Carver, General Manager.

MES developed the SQA-Vision as an intuitive tool for fertility screening, post-vasectomy follow-up, sperm banking, research or detailed IVF assessment. In addition to the predecessor’s testing modes (Fresh, Washed, Frozen, and Post Vasectomy), the SQA-Vision now includes: Density Gradient, Swim Up, Longevity, and Vitality testing options. It also provides a high-resolution visual interface, barcode scanning technology, built-in LIS capability and click-to-mark counters for assessing both sperm vitality and conducting full differential morphology.

“The beauty of the new SQA-Vision is the blend of updated technology, flexibility, and standardized testing. Depending on how semen analysis is conducted in your laboratory, the Vision can be set-up to operate in a wide range of modes. From fully automated routine screening to intensive IVF workups,” said Marcia Deutsch, CEO.

Related Links:

Medical Electronic Systems
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.